Pulmonary Toxicity due to Chemotherapy How is the Risk and Benefit from ZD1839 Treatment against Non-Small Cell Lung Cancer?
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人 日本内科学会の論文
- 2003-10-01
著者
-
SUGA Moritaka
Department of Microbiology, Kumamoto University School of Medicine
-
OKAMOTO Isamu
Department of Microbiology and Immunology, Kimmel Cancer Institute
-
Suga Moritaka
Department Of Respiratory Medicine Graduate School Of Medical Science Kumamoto University
-
Okamoto Isamu
Department Of Medical Oncology Kinki University School Of Medicine
-
Okamoto Isamu
Department Of Respiratory Medicine Graduate School Of Medical Science Kumamoto University
関連論文
- Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer
- Nitric Oxide Generation from Hydroxyurea via Copper-catalyzed Peroxidation and Implications for Pharmacological Actions of Hydroxyurea
- Expression of constitutively activated EGFRvlll in non-small cell lung cancer
- Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification
- The ER Stress Pathway Involving CHOP Is Activated in the Lungs of LPS-Treated Mice
- Pulmonary Toxicity due to Chemotherapy How is the Risk and Benefit from ZD1839 Treatment against Non-Small Cell Lung Cancer?
- Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed
- Malignant Pleural Effusion from Lung Adenocarcinoma Treated by Gefitinib
- Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan
- High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin
- Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer : KMBOG0610B